首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1029篇
  免费   53篇
  国内免费   13篇
耳鼻咽喉   2篇
儿科学   15篇
妇产科学   13篇
基础医学   157篇
口腔科学   49篇
临床医学   40篇
内科学   155篇
皮肤病学   40篇
神经病学   50篇
特种医学   23篇
外科学   163篇
综合类   45篇
预防医学   51篇
眼科学   9篇
药学   190篇
  1篇
中国医学   39篇
肿瘤学   53篇
  2023年   11篇
  2022年   23篇
  2021年   31篇
  2020年   23篇
  2019年   79篇
  2018年   82篇
  2017年   40篇
  2016年   26篇
  2015年   23篇
  2014年   58篇
  2013年   58篇
  2012年   48篇
  2011年   77篇
  2010年   38篇
  2009年   39篇
  2008年   34篇
  2007年   38篇
  2006年   21篇
  2005年   18篇
  2004年   10篇
  2003年   14篇
  2002年   12篇
  2001年   7篇
  2000年   8篇
  1999年   3篇
  1998年   9篇
  1997年   10篇
  1996年   6篇
  1995年   5篇
  1994年   2篇
  1991年   2篇
  1990年   3篇
  1988年   2篇
  1986年   1篇
  1985年   13篇
  1984年   22篇
  1983年   23篇
  1982年   16篇
  1981年   19篇
  1980年   21篇
  1979年   21篇
  1978年   21篇
  1977年   13篇
  1976年   23篇
  1975年   17篇
  1974年   11篇
  1973年   8篇
  1946年   1篇
  1944年   1篇
  1943年   3篇
排序方式: 共有1095条查询结果,搜索用时 15 毫秒
1.
2.
Mammary carcinoma (MC) is one of most common malignancy in women, and ring finger protein 2 (RNF2) possesses various roles in vast human tumors. In MC tissues as well as in cell lines RNF2 exhibited high expression, had significant association with tumor size, lymph node status, TNM stage, patients’ poor survival, and promoted cell proliferation, colony formation, cell migration and invasion of MC cell lines which was mediated by downregulation of E-cadherin protein. These data reveal that RNF2 protein plays a vital role in the development of MC and may be a potential therapy target of MC.  相似文献   
3.
犬MC1R基因多态性的研究   总被引:5,自引:0,他引:5  
目的 利用PCR—RFLP和PCR—SSCP技术分别检测犬MC1R基因中两个序列T105A和R306Ter的基因多态性,为遗传育种、培育出更加优良的实验用犬奠定基础。方法 以224只犬为实验材料,对犬MC1R基因T105A片段和R306Ter片段分别进行PCR-RFLP和PCR—SSCP分析,并且分别对具有RFLP和SSCP多态性的片段进行克隆测序,找出等位基因的差异位点。结果 经对犬MClR基因的PCR-RFLP分析,发现犬MC1R基因的T105A序列具有多态性,表现为三种基因型:AA、AB和BB。通过对具有RFLP多态性的片段进行克隆测序发现MC1R基因在编码第105位氨基酸的密码子处存在由G到A的单碱基突变,该突变导致第105位氨基酸发生由精氨酸向苏氨酸的改变,此外在第207位氨基酸的密码子处还发现由A到G的单碱基突变,并产生了一个HhαI限制性内切酶位点。同时,经过犬MC1R基因的PCR—SSCP分析,发现犬MC1R基因的R306Ter序列具有多态性,表现为三种基因型:CC、CD、DD.通过对具有SSCP多态性的片段进行了克隆测序发现,MC1R基因在编码第306位氨基酸的密码子处存在一个由CGA到TGA的终止突变,而使翻译终止。结论 利用PCR—RFLP和PCR—SSCP分析技术证实犬MC1R基因具有明显的多态性。  相似文献   
4.
Abstract: The vitamin D analogue MC 1288 (20-epi-1α,25-dihydroxycholecalciferol) effectively postpones rejection of cardiac, intestinal, skin, and aortic allografts. MC 1288 binds to the vitamin D receptor and is thus assumed to exert its immunosuppressive effects via the same mechanisms as 1α,25-dihydroxycholecalciferol, the active form of vitamin D. 1α,25-Dihydroxycholecalciferol has been demonstrated to inhibit the production of various cytokines (interleukin-2, interferon-γ, granulocyte macrophage colony-stimulating factor, and interleukin-12) and to prevent B lymphocyte secretion of immunoglobulins. In the present study MC 1288 was evaluated for its ability to prevent rejection of mouse-to-rat cardiac xenografts, alone and in combination with 15-deoxyspergualin (DSG). Combined treatment with MC 1288 (given days -1 to 9) and DSG (given day -1 and onward) postponed rejection from day 3.0 (untreated recipients) until day 19.5. In rats treated with MC 1288 or DSG as monotherapy, rejection occurred after 3.0 and 7.5 days, respectively. Functioning grafts, obtained on day 9 from recipients treated with MC 1288 and DSG in combination, displayed an almost normal morphology without any obvious deposition of immunoglobulins in the vessels of the grafts and with just a few infiltrating cells. Thus, we have demonstrated synergistic actions of MC 1288 and DSG in delaying rejection of xenografts. Analysis of cellular infiltration, immunoglobulin deposition and graft survival times in the various treatment groups indicate a combined inhibitory effect of these two drugs on the level of macrophage effector function, direct or indirect via T lymphocytes, as well as on antibody production.  相似文献   
5.
6.
7.
The peptide melittin, the main constituent of bee venom is a potent stimulus for the generation of an eosinophil chemotactic factor (ECF) from human polymorphonuclear neutrophils, rat mast cells and rat peritoneal cells depleted in mast cells. Optimal EFC induction required a sublytic activation of the cells. With each cell type the kinetics of ECF generation were similar in that after an early rise in activity a steep fall off occurred at later times of incubation suggesting a mechanism of inactivation. The induction of ECF by melittin is increased in the presence of calcium. The polar portion of the melittin molecule (aminoacids 20–26) is responsible for the generation of the chemotactic activity. Other peptides of honey bee venom such as the mast cell degranulating peptide (MCD) or apamine do not initiate ECF release. It appears that melittin leads to ECF induction via the phospholipase A2-arachidonic acid dependent pathway of cell activation. Our data suggests that the lipid mediator ECF can be obtained from phagocytes and mast cells thus indicating the interdependence of inflammatory reactions.  相似文献   
8.
9.
A reliable and reproducible immunofluorescence method is described for the detection of anti-cytoskeleton antibodies in human sera, based on the use of vinblastine-treated peripheral blood mononuclear cells as substrate. Three immunofluorescence patterns associated with antibodies to microfilaments, intermediate filaments and microtubules are readily identified.  相似文献   
10.
The suppression of skin test reactivity by single doses of six antihistamines was measured before and after a period of daily antihistamine ingestion in 18 subjects. Single doses of hydroxyzine, 50 mg; chlorpheniramine, 16 mg; and promethazine, 50 mg; induced significant suppression of skin test reactivity at 2 hr, whereas the suppression produced by tripelennamine, 100 mg; diphenhydramine, 50 mg; and cyproheptadine, 16 mg; did not differ significantly from that produced by placebo. After 3 wk of treatment with hydroxyzine, 75 mg per day, the suppressive effect of hydroxyzine as well as the five clinically unrelated antihistamines was significantly reduced. Although the response to chlorpheniramine was also reduced after chronic treatment with chlorpheniramine, 24 mg per day, the difference was not statistically significant. We conclude that antihistamines in the doses used differ greatly in their suppressive effect on skin test reactivity. The antihistamine producing the most skin test suppression, hydroxyzine, when it was taken daily for 3 wk, caused the development of partial tolerance not only to its own effect but to those of clinically unrelated antihistamines.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号